Unknown PHASE4 INTERVENTIONAL 2-arm NCT01595750

Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease (REVASC)

Sponsor: Spanish Research Center for Respiratory Diseases

Conditions Chronic Obstructive Pulmonary Disease

Updated 4 times since 2017 Last updated: May 9, 2012 Started: May 31, 2012 Primary completion: Jul 31, 2012 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01595750, this PHASE4 trial focuses on Chronic Obstructive Pulmonary Disease and remains ongoing. Sponsored by Spanish Research Center for Respiratory Diseases, it has been updated 4 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE4

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Spanish Research Center for Respiratory Diseases

Data source: Spanish Research Center for Respiratory Diseases

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bunyola, Spain